5:40 PM
 | 
Mar 01, 2013
 |  BC Extra  |  Financial News

Keryx gains on GSK takeout chatter

Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) gained $0.76 (12%) to $7.19 on Friday after media reports said that GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) is considering acquiring the...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >